Hydrogen Water Plus Duloxetine Prevents Chemo Nerve Pain in Mice
Preventing Cisplatin-Induced Neuropathy and Related Emotional Disorders with the Coadministration of Duloxetine and Hydrogen-Rich Water in Male and Female Mice
Research hubs: Brain & Nervous System · Musculoskeletal System
- Evidence type
- Animal study (mouse)
- Authors
- Ignacio Martínez-Martel, Sylmara Esther Negrini-Ferrari, Olga Pol
- Journal
- Antioxidants
- Year
- 2025
- DOI
- 10.3390/antiox14081004
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Spain
- Health Condition
- Peripheral Neuropathy
- Body System
- Nervous System
This research was done in animals. Results in animals often don't carry over to people.
TL;DR
Combining hydrogen-rich water with low-dose duloxetine helped prevent nerve pain, mood issues, and muscle problems caused by chemotherapy in mice.
Key Finding
In mice, combining duloxetine with hydrogen-rich water prevented cisplatin-induced nerve pain more effectively than either treatment given separately, with additional benefits for muscle function and emotional symptoms.
Summary
This study tested whether combining a medication called duloxetine with hydrogen-rich water could prevent nerve pain and mood problems in mice treated with cisplatin, a chemotherapy drug. In mice, the combination treatment prevented pain sensations and muscle weakness better than either treatment alone, and it also reduced anxiety and depression-like behaviors. The researchers believe the combination works by reducing inflammation and oxidative stress (cellular damage) in nerve tissue.
Practical Takeaway
This is early-stage research in mice only, so it cannot yet be applied to humans. While the results suggest that hydrogen-rich water combined with duloxetine may have promise for preventing chemotherapy-related nerve damage, human clinical trials would be needed to determine if this approach is safe and effective for cancer patients. Anyone undergoing chemotherapy should discuss prevention strategies with their oncologist rather than self-treating.
Abstract (excerpt)
Cisplatin (CIS)-induced peripheral neuropathy and associated comorbidities have a detrimental effect on the lives of cancer patients. Currently, there are no effective therapies to alleviate these symptoms. Duloxetine (DULO) is a recommended treatment, but it is linked with important side effects…